Paul V. Plourde

Arimidex�: A potent and selective fourth-generation aromatase inhibitor

Paul V. Plourde, Martin C. Dyroff, Michael Dukes · Breast Cancer Research and Treatment · 1994 · 257 citations

Pharmacy, Medicinal Chemistry, Pharmacology +9

A Phase III trial comparing anastrozole (1 and 10 milligrams), a potent and selective aromatase inhibitor, with megestrol acetate in postmenopausal women with advanced breast carcinoma

Aman U. Buzdar, Stephen E. Jones, Charles L. Vogel et al. · Cancer · 1997 · 208 citations

Medicine, Oncology, Pharmacology +17

Tamoxifen treatment for precocious puberty in McCune-Albright syndrome: a multicenter trial

Erica A. Eugster, Stephen D. Rubin, Edward O. Reiter et al. · The Journal of Pediatrics · 2003 · 164 citations

Medicine, Endocrinology, Pediatrics +10

Safety and Efficacy of Anastrozole for the Treatment of Pubertal Gynecomastia: A Randomized, Double-Blind, Placebo-Controlled Trial

Paul V. Plourde, Edward O. Reiter, Hann-Chang Jou et al. · The Journal of Clinical Endocrinology & Metabolism · 2004 · 130 citations

Medicine, Endocrinology, Pharmacology +17

Erwinia asparaginase achieves therapeutic activity after pegaspargase allergy: a report from the Children’s Oncology Group

Wanda L. Salzer, Barbara L. Asselin, Jeffrey G. Supko et al. · Blood · 2013 · 82 citations · Full text

Life Sciences, Pediatrics, Pharmacotherapy +7